JP Patent

JP7354342B2 — タウ発現を調節するための組成物

Assigned to Biogen MA Inc · Expires 2023-10-02 · 3y expired

What this patent protects

Patent listed against inotersen-sodium.

Drugs covered by this patent

inotersen-sodium (INOTERSEN SODIUM)

Patent Metadata

Patent number: JP7354342B2
Jurisdiction: JP
Classification: —
Expires: 2023-10-02
Drug substance claim: No
Drug product claim: No
Assignee: Biogen MA Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.